Head and neck mucosal melanoma: The United Kingdom national guidelines.

[1]  P. Ascierto,et al.  CheckMate 067: Long-term outcomes in patients with mucosal melanoma. , 2020 .

[2]  G. Calais,et al.  Oncologic outcomes, prognostic factor analysis and therapeutic algorithm evaluation of head and neck mucosal melanomas in France. , 2019, European journal of cancer.

[3]  K. Flaherty,et al.  Axitinib in Combination With Toripalimab, a Humanized Immunoglobulin G4 Monoclonal Antibody Against Programmed Cell Death-1, in Patients With Metastatic Mucosal Melanoma: An Open-Label Phase IB Trial , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  D. Hoon,et al.  Predominance of triple wild-type and IGF2R mutations in mucosal melanomas , 2018, BMC Cancer.

[5]  M. Amit,et al.  Patterns of Treatment Failure in Patients with Sinonasal Mucosal Melanoma , 2018, Annals of Surgical Oncology.

[6]  L. Stolle,et al.  Mucosal Melanoma: a Literature Review , 2018, Current Oncology Reports.

[7]  M. Amit,et al.  Contemporary Treatment Approaches to Sinonasal Mucosal Melanoma , 2018, Current Oncology Reports.

[8]  A. Hauschild,et al.  Adjuvant Dabrafenib plus Trametinib in Stage III BRAF‐Mutated Melanoma , 2017, The New England journal of medicine.

[9]  P. Ascierto,et al.  Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma , 2017, The New England journal of medicine.

[10]  G. Botti,et al.  Mucosal melanoma of the head and neck. , 2017, Critical reviews in oncology/hematology.

[11]  S. Bhide,et al.  Mucosal melanoma of the upper airways tract mucosal melanoma: A systematic review with meta‐analyses of treatment , 2017, Head & neck.

[12]  Ying Wang,et al.  Treatment and outcomes of endoscopic surgery and traditional open resection in sinonasal mucosal melanoma , 2017, Acta oto-laryngologica.

[13]  Yoko Takahashi,et al.  Mutation Status in Sinonasal Mucosal Melanoma , 2017, Journal of Neurological Surgery Part B: Skull Base.

[14]  K. Savage,et al.  Efficacy and Safety of Nivolumab Alone or in Combination With Ipilimumab in Patients With Mucosal Melanoma: A Pooled Analysis. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  R. Gutzmer,et al.  Clinics, prognosis and new therapeutic options in patients with mucosal melanoma , 2017, Medicine.

[16]  W. Guo,et al.  Mutation scanning of BRAF, NRAS, KIT, and GNAQ/GNA11 in oral mucosal melanoma: a study of 57 cases. , 2016, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[17]  E. Zepeda-Castilla,et al.  Comparative study between two different staging systems (AJCC TNM VS BALLANTYNE’S) for mucosal melanomas of the Head & Neck , 2016, Medicina oral, patologia oral y cirugia bucal.

[18]  S. Friis,et al.  Primary mucosal melanoma of the head and neck in Denmark, 1982–2012: Demographic and clinical aspects. A retrospective DAHANCA study , 2016, Acta oncologica.

[19]  O. Taşkın,et al.  Clinicopathologic and molecular features of mucosal melanoma: Data from a tertiary care center , 2016 .

[20]  Ö. Ekinci,et al.  Mucosal melanoma of the head and neck: recurrence characteristics and survival outcomes. , 2015, Oral surgery, oral medicine, oral pathology and oral radiology.

[21]  Wei Li,et al.  Evaluation of the prognostic impact of postoperative adjuvant radiotherapy on head and neck mucosal melanoma: a meta-analysis , 2015, BMC Cancer.

[22]  A. D. Van den Abbeele,et al.  Imatinib for melanomas harboring mutationally activated or amplified KIT arising on mucosal, acral, and chronically sun-damaged skin. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  J. Chan,et al.  Mucosal melanoma of the head and neck: 32‐year experience in a tertiary referral hospital , 2012, The Laryngoscope.

[24]  Wei Guo,et al.  Primary oral mucosal melanoma: advocate a wait-and-see policy in the clinically N0 patient. , 2012, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[25]  J. Shah,et al.  Mucosal melanoma of the head and neck. , 2012, Journal of the National Comprehensive Cancer Network : JNCCN.

[26]  J. Shah,et al.  Clinicopathologic differences in malignant melanoma arising in oral squamous and sinonasal respiratory mucosa of the upper aerodigestive tract. , 2003, Archives of pathology & laboratory medicine.

[27]  A. Meneses-García,et al.  Malignant melanoma of the oral cavity: diagnosis and treatment experience in a Mexican population. , 1999, Oral oncology.

[28]  B. Wenig.  Laryngeal mucosal malignant melanoma. A clinicopathologic, immunohistochemical, and ultrastructural study of four patients and a review of the literature , 1995, Cancer.

[29]  L. Sobin,et al.  TNM Classification of Malignant Tumours , 1987, UICC International Union Against Cancer.

[30]  A. Ballantyne.  Malignant melanoma of the skin of the head and neck. An analysis of 405 cases. , 1970, American journal of surgery.